Annual Current Liabilities
$58.44 M
+$3.23 M+5.85%
31 December 2023
Summary:
Foghorn Therapeutics annual total current liabilities is currently $58.44 million, with the most recent change of +$3.23 million (+5.85%) on 31 December 2023. During the last 3 years, it has risen by +$39.59 million (+210.07%). FHTX annual current liabilities is now at all-time high.FHTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$56.82 M
+$5.95 M+11.70%
30 September 2024
Summary:
Foghorn Therapeutics quarterly total current liabilities is currently $56.82 million, with the most recent change of +$5.95 million (+11.70%) on 30 September 2024. Over the past year, it has increased by +$4.81 million (+9.25%). FHTX quarterly current liabilities is now -2.76% below its all-time high of $58.44 million, reached on 31 December 2023.FHTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.8% | +9.3% |
| 3 y3 years | +210.1% | +194.5% |
| 5 y5 years | +1589.4% | - |
FHTX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +210.1% | -2.8% | +194.5% |
| 5 y | 5 years | at high | +1589.4% | -2.8% | +349.1% |
| alltime | all time | at high | +1589.4% | -2.8% | +349.1% |
Foghorn Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $56.82 M(+11.7%) |
| June 2024 | - | $50.87 M(-2.3%) |
| Mar 2024 | - | $52.06 M(-10.9%) |
| Dec 2023 | $58.44 M(+5.9%) | $58.44 M(+12.4%) |
| Sept 2023 | - | $52.01 M(-8.2%) |
| June 2023 | - | $56.64 M(+1.5%) |
| Mar 2023 | - | $55.80 M(+1.1%) |
| Dec 2022 | $55.20 M | $55.20 M(-0.0%) |
| Sept 2022 | - | $55.21 M(+15.1%) |
| June 2022 | - | $47.97 M(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $48.24 M(-0.9%) |
| Dec 2021 | $48.69 M(+158.4%) | $48.69 M(+152.3%) |
| Sept 2021 | - | $19.30 M(+17.6%) |
| June 2021 | - | $16.41 M(+0.5%) |
| Mar 2021 | - | $16.33 M(-13.3%) |
| Dec 2020 | $18.85 M(+49.0%) | $18.85 M(-11.5%) |
| Sept 2020 | - | $21.30 M(+34.3%) |
| June 2020 | - | $15.87 M(+25.4%) |
| Dec 2019 | $12.65 M(+265.8%) | $12.65 M |
| Dec 2018 | $3.46 M | - |
FAQ
- What is Foghorn Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual current liabilities year-on-year change?
- What is Foghorn Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly current liabilities year-on-year change?
What is Foghorn Therapeutics annual total current liabilities?
The current annual current liabilities of FHTX is $58.44 M
What is the all time high annual current liabilities for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual total current liabilities is $58.44 M
What is Foghorn Therapeutics annual current liabilities year-on-year change?
Over the past year, FHTX annual total current liabilities has changed by +$3.23 M (+5.85%)
What is Foghorn Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of FHTX is $56.82 M
What is the all time high quarterly current liabilities for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly total current liabilities is $58.44 M
What is Foghorn Therapeutics quarterly current liabilities year-on-year change?
Over the past year, FHTX quarterly total current liabilities has changed by +$4.81 M (+9.25%)